Found: 10
Select item for more details and to access through your institution.
The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 9, p. 2499, doi. 10.1007/s13300-021-01125-8
- By:
- Publication type:
- Article
Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial.
- Published in:
- Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-01879-4
- By:
- Publication type:
- Article
Effect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial.
- Published in:
- Cardiovascular Diabetology, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12933-020-01206-1
- By:
- Publication type:
- Article
Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 5, p. 999, doi. 10.1007/s13300-017-0292-1
- By:
- Publication type:
- Article
Characterization of premature atherosclerosis of carotid arteries in acromegalic patients.
- Published in:
- Clinical Endocrinology, 2001, v. 54, n. 6, p. 791, doi. 10.1046/j.1365-2265.2001.01281.x
- By:
- Publication type:
- Article
Impaired β-cell function in the presence of reduced insulin sensitivity determines glucose tolerance status in acromegalic patients.
- Published in:
- Clinical Endocrinology, 2000, v. 52, n. 5, p. 549, doi. 10.1046/j.1365-2265.2000.00986.x
- By:
- Publication type:
- Article
Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study.
- Published in:
- Cardiovascular Diabetology, 2020, v. 19, n. 1, p. 1, doi. 10.1186/s12933-020-01079-4
- By:
- Publication type:
- Article
Suramin interrupts androgen-inducible autocrine loop involving heparin binding growth factor in mouse mammary cancer (Shionogi carcinoma 115) cells.
- Published in:
- Journal of Cellular Physiology, 1993, v. 154, n. 2, p. 254, doi. 10.1002/jcp.1041540207
- By:
- Publication type:
- Article
Heparin inhibits autocrine stimulation but not fibroblast growth factor stimulation of cell proliferation of androgen-responsive shionogi carcinoma 115.
- Published in:
- Journal of Cellular Physiology, 1991, v. 148, n. 2, p. 260, doi. 10.1002/jcp.1041480211
- By:
- Publication type:
- Article
Metformin decreases glycated albumin to glycated haemoglobin ratio in patients with newly diagnosed type 2 diabetes.
- Published in:
- Annals of Clinical Biochemistry, 2015, v. 52, n. 1, p. 76, doi. 10.1177/0004563214522984
- By:
- Publication type:
- Article